SCHEMBL2182287

SCHEMBL2182287

CCN(CC)CCNCCCN

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.56
CA12 O43570 4/20 0.52
CA6 P23280 4/20 0.52
CA7 P43166 4/20 0.52
CA9 Q16790 4/20 0.52
CA14 Q9ULX7 4/20 0.52
CA5B Q9Y2D0 4/20 0.52
CA2 P00918 3/20 0.52
CA4 P22748 3/20 0.52
CA5A P35218 3/20 0.52
ALOX15 P16050 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
CASP2 P42575 2/20 0.52
F13A1 P00488 2/20 0.52
CYP1A2 P05177 2/20 0.52
THPO P40225 2/20 0.52
CYP2C19 P33261 2/20 0.52
RECQL P46063 2/20 0.52
HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL323710 0.91 TDP1 (0.61) TDP1CA12CA6CA7CA9
SCHEMBL323463 0.91 CYP2C19 (0.58) TDP1CA12CA6CA7CA9
SCHEMBL7522951 0.89 ALOX15 (0.56) TDP1CA12CA6CA7CA9
SCHEMBL427900 0.89 TDP1 (0.59) TDP1CA12CA6CA7CA9
SCHEMBL30607521 0.88 CYP2C19 (0.56) TDP1CA12CA6CA7CA9
SCHEMBL11871853 0.88 CYP2C19 (0.56) TDP1CA12CA6CA7CA9
Hydrochloric Acid SCHEMBL6114403 0.87 UBE2N (0.58) TDP1CA12CA6CA7CA9
Hydrochloric Acid SCHEMBL28341342 0.87 UBE2N (0.58) TDP1CA12CA6CA7CA9
SCHEMBL10123951 0.86 CYP2C19 (0.58) TDP1CA12CA6CA7CA9
SCHEMBL11323396 0.85 PAOX (0.48) TDP1CA12CA6CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US claimed
WO-2010014798-A2 PYRIMIDOTRIAZINEDIONES AND PYRIMIDOPYRIMIDINEDIONES AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-02-04 WO claimed
US-20230181524-A1 PHARMACEUTICAL COMBINATION AND USE THEREOF NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) 2023-06-15 US disclosed
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed
WO-2010014798-A2 PYRIMIDOTRIAZINEDIONES AND PYRIMIDOPYRIMIDINEDIONES AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-02-04 WO disclosed
US-5639582-A Electrophotographic toner composition and process for the preparation thereof FUJI XEROX CO., LTD. (JP) 1997-06-17 US disclosed
EP-0017122-B1 USE OF VONEL QUATERNARY POLYSILOXANE DERIVATIVES IN HAIR COSMETICS, AND HAIR WASHING AND HAIR TREATMENT COMPOSITIONS CONTAINING THEM Henkel Kommanditgesellschaft auf Aktien (DE) 1983-06-15 EP disclosed
EP-0017121-B1 QUATERNARY POLYSILOXANE DERIVATIVES, THEIR USE IN HAIR COSMETICS, AND HAIR WASHING AND HAIR TREATMENT COMPOSITIONS CONTAINING THEM Henkel Kommanditgesellschaft auf Aktien (DE) 1983-04-20 EP disclosed
EP-0017122-A1 Use of vonel quaternary polysiloxane derivatives in hair cosmetics, and hair washing and hair treatment compositions containing them Henkel Kommanditgesellschaft auf Aktien (DE) 1980-10-15 EP disclosed
EP-0017121-A1 Quaternary polysiloxane derivatives, their use in hair cosmetics, and hair washing and hair treatment compositions containing them Henkel Kommanditgesellschaft auf Aktien (DE) 1980-10-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230181524-A1 PHARMACEUTICAL COMBINATION AND USE THEREOF TCF4, TCF7L2, CTNNB1 TDP1 3665/4885CA12 1352/4885CA6 1027/4885
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR TDP1 941/4885CA12 3644/4885CA6 1357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.